Correlation Between Nexalin Technology and Bone Biologics

Can any of the company-specific risk be diversified away by investing in both Nexalin Technology and Bone Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nexalin Technology and Bone Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Nexalin Technology and Bone Biologics Corp, you can compare the effects of market volatilities on Nexalin Technology and Bone Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nexalin Technology with a short position of Bone Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nexalin Technology and Bone Biologics.

Diversification Opportunities for Nexalin Technology and Bone Biologics

-0.86

Correlation Coefficient

Nexalin Technology  Bone Biologics

Pay attention - limited upside

The 3 months correlation between Nexalin and Bone is -0.86. Overlapping area represents the amount of risk that can be diversified away by holding Nexalin Technology and Bone Biologics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bone Biologics Corp and Nexalin Technology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nexalin Technology are associated (or correlated) with Bone Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bone Biologics Corp has no effect on the direction of Nexalin Technology i.e., Nexalin Technology and Bone Biologics go up and down completely randomly.

Pair Corralation between Nexalin Technology and Bone Biologics

Considering the 90-day investment horizon Nexalin Technology is expected to generate 0.52 times more return on investment than Bone Biologics. However, Nexalin Technology is 1.94 times less risky than Bone Biologics. It trades about 0.25 of its potential returns per unit of risk. Bone Biologics Corp is currently generating about 0.06 per unit of risk. If you would invest  90.00  in Nexalin Technology on August 31, 2024 and sell it today you would earn a total of  337.00  from holding Nexalin Technology or generate 374.44% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Nexalin Technology  vs.  Bone Biologics Corp

Nexalin Technology

Risk-Adjusted Performance

20 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Nexalin Technology are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. Despite quite abnormal basic indicators, Nexalin Technology disclosed solid returns over the last few months and may actually be approaching a breakup point.

Bone Biologics Corp

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Bone Biologics Corp are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile technical and fundamental indicators, Bone Biologics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Nexalin Technology and Bone Biologics

The main advantage of trading using opposite Nexalin Technology and Bone Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nexalin Technology position performs unexpectedly, Bone Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bone Biologics will offset losses from the drop in Bone Biologics' long position.

The idea behind Nexalin Technology and Bone Biologics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.